Toggle navigation
Home
Search
Services
Blog
Contact
About
Novel Recombinant Serpin for the Treatment of Stroke
Sands, Howard
Sparta Pharmaceutical Corporation, Horsham, PA, United States
Search 7 grants from Howard Sands
Search grants from Sparta Pharmaceutical Corporation
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Massachusetts Institute of Technology
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Structural Basis of Gene Regulation by Polycomb Repressive Complex 2
Structure function studies in intestinal epithelial JAM
A flow cytometer for multi-color cell analysis in a multi-user facility
Gluconeogenesis in the Very Low Birth Weight Infant
Grants for Predoctoral Training in Family Medicine
Recently added grants:
Mentoring and Research in Patient-Oriented Integrative Medicine
The Role of TRIM28 Phosphorylation in the Mechanical Regulation of Skeletal Muscle
Implementation of a Pragmatic Trial of Whole Health Team vs. Primary Care Group Education to Promote Non-Pharmacological Strategies to Improve Pain, Function and Quality of Life in Veterans
Preoperative Image Updating for Guidance during Brain Tumor Resection
Epigenetic Mechanisms Driving Synovial Sarcomagenesis
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Small Business Innovation Research Grants (SBIR) - Phase II (R44)
Project #
5R44NS036100-03
Application #
2771968
Study Section
Special Emphasis Panel (ZRG3-SSS-Z (11))
Program Officer
Jacobs, Tom P
Project Start
1995-08-15
Project End
1999-08-31
Budget Start
1998-09-01
Budget End
1999-08-31
Support Year
3
Fiscal Year
1998
Total Cost
Indirect Cost
Institution
Name
Sparta Pharmaceutical Corporation
Department
Type
DUNS #
City
Horsham
State
PA
Country
United States
Zip Code
19044
Related projects
NIH 1998
R44 NS
Novel Recombinant Serpin for the Treatment of Stroke
Sands, Howard / Sparta Pharmaceutical Corporation
NIH 1997
R44 NS
Novel Recombinant Serpin for the Treatment of Stroke
Sands, Howard / Sparta Pharmaceutical Corporation
Comments
Be the first to comment on Howard Sands's grant